Trial Profile
A Pharmacokinetic Study of the Agile TCDS AG200-15 Following Weekly Application to Three Anatomical Sites (Abdomen, Buttock and Upper Torso) in Healthy Female Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Jan 2019
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/levonorgestrel (Primary)
- Indications Pregnancy
- Focus Pharmacokinetics
- Sponsors Agile Therapeutics
- 18 May 2012 Results presented at the 60th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists.
- 10 May 2012 Primary endpoint 'Peak-drug-concentration' has been met.
- 10 May 2012 Primary endpoint 'Drug-clearance' has been met.